NCT04596033 2022-07-15
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Genocea Biosciences, Inc.
Phase 1 Terminated
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
National Institutes of Health Clinical Center (CC)